295 related articles for article (PubMed ID: 22118836)
1. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
2. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
4. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.
Loued S; Isabelle M; Berrougui H; Khalil A
Life Sci; 2012 Jan; 90(1-2):82-8. PubMed ID: 22067439
[TBL] [Abstract][Full Text] [Related]
6. Macrophage paraoxonase 1 (PON1) binding sites.
Efrat M; Aviram M
Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
[TBL] [Abstract][Full Text] [Related]
7. An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats.
Farid AS; Mido S; Linh BK; Hayashi T; Horii Y
Eur J Clin Invest; 2010 Nov; 40(11):984-93. PubMed ID: 20695884
[TBL] [Abstract][Full Text] [Related]
8. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
9. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
11. Main determinants of PON1 activity in hemodialysis patients.
Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
[TBL] [Abstract][Full Text] [Related]
12. Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.
Loued S; Berrougui H; Componova P; Ikhlef S; Helal O; Khalil A
Br J Nutr; 2013 Oct; 110(7):1272-84. PubMed ID: 23510814
[TBL] [Abstract][Full Text] [Related]
13. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
14. [Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment].
Sapian-Raczkowska B; Rabczyński M; Adamiec R
Pol Merkur Lekarski; 2010 Nov; 29(173):325-7. PubMed ID: 21268919
[TBL] [Abstract][Full Text] [Related]
15. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
16. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
17. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 and homocysteine metabolism.
Perła-Kaján J; Jakubowski H
Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
[TBL] [Abstract][Full Text] [Related]
19. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
20. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
Mackness B; Quarck R; Verreth W; Mackness M; Holvoet P
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1545-50. PubMed ID: 16627808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]